Stock CYCC CYCLACEL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Cyclacel Pharmaceuticals, Inc.

Equities

CYCC

US23254L8019

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/06/2024 BST 		5-day change 1st Jan Change
1.69 USD +2.42% Intraday chart for Cyclacel Pharmaceuticals, Inc. -15.50% -36.70%
06-03 Cyclacel Pharmaceuticals, Inc. Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib?s Potential as Precision Medicine for Cancer CI
05-14 Cyclacel Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CYCLACEL PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+2.42%-15.50%-36.70%-82.93%-98.94% 2.47M
Bearish
Neutral
Bearish
  1. Stock Market
  2. Equities
  3. CYCC Stock
  4. Charts Cyclacel Pharmaceuticals, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW